A 0 1 0 1 O
life 2 6 2 6 B-clinical_variable
expectancy 7 17 7 17 I-clinical_variable
of 18 20 18 20 O
greater 21 28 21 28 O
than 29 33 29 33 O
24 34 36 34 36 B-lower_bound
weeks 37 42 37 42 I-lower_bound
at 43 45 43 45 O
Screening 46 55 46 55 O

Any 0 3 56 59 O
concurrent 4 14 60 70 O
uncontrolled 15 27 71 83 O
illness 28 35 84 91 O
, 35 36 91 92 O
including 37 46 93 102 O
mental 47 53 103 109 B-chronic_disease
illness 54 61 110 117 I-chronic_disease
or 62 64 118 120 O
substance 65 74 121 130 O
abuse 75 80 131 136 O
, 80 81 136 137 O
which 82 87 138 143 O
in 88 90 144 146 O
the 91 94 147 150 O
opinion 95 102 151 158 O
of 103 105 159 161 O
the 106 109 162 165 O
Investigator 110 122 166 178 O

Eastern 0 7 179 186 B-clinical_variable
Cooperative 8 19 187 198 I-clinical_variable
Oncology 20 28 199 207 I-clinical_variable
Group 29 34 208 213 I-clinical_variable
( 35 36 214 215 I-clinical_variable
ECOG 36 40 215 219 I-clinical_variable
) 40 41 219 220 I-clinical_variable
performance 42 53 221 232 I-clinical_variable
status 54 60 233 239 I-clinical_variable
of 61 63 240 242 O
0 64 65 243 244 B-lower_bound
to 66 68 245 247 O
1 69 70 248 249 B-upper_bound

Histopathologically 0 19 250 269 O
confirmed 20 29 270 279 O
diagnosis 30 39 280 289 O
of 40 42 290 292 O
metastatic 43 53 293 303 B-cancer
or 54 56 304 306 I-cancer
unresectable 57 69 307 319 I-cancer
malignant 70 79 320 329 I-cancer
melanoma 80 88 330 338 I-cancer

Known 0 5 339 344 O
infection 6 15 345 354 O
with 16 20 355 359 O
human 21 26 360 365 B-chronic_disease
immunodeficiency 27 43 366 382 I-chronic_disease
virus 44 49 383 388 I-chronic_disease
( 50 51 389 390 I-chronic_disease
HIV 51 54 390 393 I-chronic_disease
) 54 55 393 394 I-chronic_disease
, 55 56 394 395 O
hepatitis 57 66 396 405 B-chronic_disease
B 67 68 406 407 I-chronic_disease
virus 69 74 408 413 I-chronic_disease
( 75 76 414 415 I-chronic_disease
HBV 76 79 415 418 I-chronic_disease
) 79 80 418 419 I-chronic_disease
or 81 83 420 422 O
hepatitis 84 93 423 432 B-chronic_disease
C 94 95 433 434 I-chronic_disease
virus 96 101 435 440 I-chronic_disease
( 102 103 441 442 I-chronic_disease
HCV 103 106 442 445 I-chronic_disease
) 106 107 445 446 I-chronic_disease

Lactate 0 7 447 454 B-clinical_variable
dehydrogenase 8 21 455 468 I-clinical_variable
( 22 23 469 470 I-clinical_variable
LDH 23 26 470 473 I-clinical_variable
) 26 27 473 474 I-clinical_variable
< 28 29 475 476 O
= 29 30 476 477 O
2.0 30 33 477 480 B-upper_bound
times 34 39 481 486 I-upper_bound
the 40 43 487 490 I-upper_bound
ULN 44 47 491 494 I-upper_bound
range 48 53 495 500 O
of 54 56 501 503 O
each 57 61 504 508 O
institution 62 73 509 520 O

Ocular 0 6 521 527 B-cancer
melanoma 7 15 528 536 I-cancer
participants 16 28 537 549 O

Pregnant 0 8 550 558 B-pregnancy

Received 0 8 559 567 O
treatment 9 18 568 577 B-treatment
with 19 23 578 582 I-treatment
anti- 24 29 583 588 I-treatment
cytotoxic 30 39 589 598 I-treatment
T 40 41 599 600 I-treatment
- 41 42 600 601 I-treatment
lymphocyte 42 52 601 611 I-treatment
- 52 53 611 612 I-treatment
associated 53 63 612 622 I-treatment
protein 64 71 623 630 I-treatment
4 72 73 631 632 I-treatment
( 74 75 633 634 I-treatment
anti 75 79 634 638 I-treatment
- 79 80 638 639 I-treatment
CTLA-4 80 86 639 645 I-treatment
) 86 87 645 646 I-treatment
antibody 88 96 647 655 I-treatment
within 97 103 656 662 O
30 104 106 663 665 B-upper_bound
days 107 111 666 670 I-upper_bound
prior 112 117 671 676 I-upper_bound
to 118 120 677 679 O
the 121 124 680 683 O
start 125 130 684 689 O
of 131 133 690 692 O
CMP-001 134 141 693 700 O
dosing 142 148 701 707 O
on 149 151 708 710 O
Week 152 156 711 715 O
1 157 158 716 717 O
Day 159 162 718 721 O
1 163 164 722 723 O

Require 0 7 724 731 O
systemic 8 16 732 740 O
pharmacologic 17 30 741 754 O
doses 31 36 755 760 O
of 37 39 761 763 O
corticosteroids 40 55 764 779 B-treatment
at 56 58 780 782 O
or 59 61 783 785 O
above 62 67 786 791 O
the 68 71 792 795 O
equivalent 72 82 796 806 O
of 83 85 807 809 O
10 86 88 810 812 B-lower_bound
mg 89 91 813 815 I-lower_bound
/ 91 92 815 816 I-lower_bound
day 92 95 816 819 I-lower_bound
prednisone 96 106 820 830 B-treatment

Requires 0 8 831 839 O
prohibited 9 19 840 850 O
treatment 20 29 851 860 O
that 30 34 861 865 O
is 35 37 866 868 O
, 37 38 868 869 O
non 39 42 870 873 O
- 42 43 873 874 O
protocol 43 51 874 882 O
specified 52 61 883 892 O
anticancer 62 72 893 903 O
. 72 73 903 904 O
pharmacotherapy 74 89 905 920 B-treatment
, 89 90 920 921 O
surgery 91 98 922 929 B-treatment
or 99 101 930 932 O
conventional 102 114 933 945 B-treatment
radiotherapy 115 127 946 958 I-treatment
for 128 131 959 962 O
treatment 132 141 963 972 O
of 142 144 973 975 O
malignant 145 154 976 985 B-cancer
tumor 155 160 986 991 I-cancer
) 160 161 991 992 O

Severe 0 6 993 999 O
uncontrolled 7 19 1000 1012 O
cardiac 20 27 1013 1020 B-chronic_disease
disease 28 35 1021 1028 I-chronic_disease
within 36 42 1029 1035 O
6 43 44 1036 1037 B-upper_bound
months 45 51 1038 1044 I-upper_bound
of 52 54 1045 1047 O
screening 55 64 1048 1057 O
, 64 65 1057 1058 O
including 66 75 1059 1068 O
but 76 79 1069 1072 O
not 80 83 1073 1076 O
limited 84 91 1077 1084 O
to 92 94 1085 1087 O
uncontrolled 95 107 1088 1100 O
hypertension 108 120 1101 1113 B-chronic_disease
; 120 121 1113 1114 O
unstable 122 130 1115 1123 B-chronic_disease
angina 131 137 1124 1130 I-chronic_disease
; 137 138 1130 1131 O
myocardial 139 149 1132 1142 B-chronic_disease
infarction 150 160 1143 1153 I-chronic_disease
( 161 162 1154 1155 I-chronic_disease
MI 162 164 1155 1157 I-chronic_disease
) 164 165 1157 1158 I-chronic_disease
or 166 168 1159 1161 O
cerebrovascular 169 184 1162 1177 B-chronic_disease
accident 185 193 1178 1186 I-chronic_disease
( 194 195 1187 1188 I-chronic_disease
CVA 195 198 1188 1191 I-chronic_disease
) 198 199 1191 1192 I-chronic_disease

Women 0 5 1193 1198 B-gender
of 6 8 1199 1201 O
child 9 14 1202 1207 O
- 14 15 1207 1208 O
bearing 15 22 1208 1215 O
potential 23 32 1216 1225 O
who 33 36 1226 1229 O
are 37 40 1230 1233 O
unable 41 47 1234 1240 B-contraception_consent
or 48 50 1241 1243 I-contraception_consent
unwilling 51 60 1244 1253 I-contraception_consent
to 61 63 1254 1256 I-contraception_consent
use 64 67 1257 1260 I-contraception_consent
an 68 70 1261 1263 I-contraception_consent
acceptable 71 81 1264 1274 I-contraception_consent
method 82 88 1275 1281 I-contraception_consent
of 89 91 1282 1284 I-contraception_consent
contraception 92 105 1285 1298 I-contraception_consent

currently 0 9 1299 1308 O
receiving 10 19 1309 1318 O
treatment 20 29 1319 1328 O
with 30 34 1329 1333 O
the 35 38 1334 1337 O
anti 39 43 1338 1342 B-treatment
- 43 44 1342 1343 I-treatment
PD-1 44 48 1343 1347 I-treatment
antibody 49 57 1348 1356 I-treatment
pembrolizumab 58 71 1357 1370 I-treatment
either 72 78 1371 1377 O
alone 79 84 1378 1383 O
or 85 87 1384 1386 O
in 88 90 1387 1389 O
combination 91 102 1390 1401 O

have 0 4 1402 1406 O
a 5 6 1407 1408 O
best 7 11 1409 1413 O
response 12 20 1414 1422 O
of 21 23 1423 1425 O
either 24 30 1426 1432 O
Stable 31 37 1433 1439 B-chronic_disease
Disease 38 45 1440 1447 I-chronic_disease
( 46 47 1448 1449 I-chronic_disease
SD 47 49 1449 1451 I-chronic_disease
) 49 50 1451 1452 I-chronic_disease
or 51 53 1453 1455 O
Progressive 54 65 1456 1467 B-chronic_disease
Disease 66 73 1468 1475 I-chronic_disease
( 74 75 1476 1477 I-chronic_disease
PD 75 77 1477 1479 I-chronic_disease
) 77 78 1479 1480 I-chronic_disease
per 79 82 1481 1484 O
RECIST 83 89 1485 1491 O
Version 90 97 1492 1499 O
1.1 98 101 1500 1503 O
while 102 107 1504 1509 O
on 108 110 1510 1512 O
pembrolizumab 111 124 1513 1526 B-treatment

neutrophil 0 10 1527 1537 B-clinical_variable
count 11 16 1538 1543 I-clinical_variable
greater 17 24 1544 1551 O
than 25 29 1552 1556 O
or 30 32 1557 1559 O
equal 33 38 1560 1565 O
to 39 41 1566 1568 O
( 42 43 1569 1570 O
> 43 44 1570 1571 O
/= 44 46 1571 1573 O
) 46 47 1573 1574 O
1,000 48 53 1575 1580 B-lower_bound
/ 53 54 1580 1581 I-lower_bound
cubic 54 59 1581 1586 I-lower_bound
millimeter 60 70 1587 1597 I-lower_bound
( 71 72 1598 1599 I-lower_bound
mm^3 72 76 1599 1603 I-lower_bound
) 76 77 1603 1604 I-lower_bound

platelet 0 8 1605 1613 B-clinical_variable
count 9 14 1614 1619 I-clinical_variable
> 15 16 1620 1621 O
/=75,000 16 24 1621 1629 O
/ 24 25 1629 1630 I-lower_bound
mm^3 25 29 1630 1634 I-lower_bound

replacement 0 11 1635 1646 O
doses 12 17 1647 1652 O
, 17 18 1652 1653 O
topical 19 26 1654 1661 B-treatment
, 26 27 1661 1662 O
ophthalmologic 28 42 1663 1677 B-treatment
and 43 46 1678 1681 O
inhalational 47 59 1682 1694 B-treatment
steroids 60 68 1695 1703 I-treatment

serum 0 5 1704 1709 B-clinical_variable
creatinine 6 16 1710 1720 I-clinical_variable
< 17 18 1721 1722 O
= 18 19 1722 1723 O
1.5 19 22 1723 1726 B-upper_bound
times 23 28 1727 1732 I-upper_bound
the 29 32 1733 1736 I-upper_bound
ULN 33 36 1737 1740 I-upper_bound
range 37 42 1741 1746 O
of 43 45 1747 1749 O
each 46 50 1750 1754 O
institution 51 62 1755 1766 O

total 0 5 1767 1772 B-clinical_variable
bilirubin 6 15 1773 1782 I-clinical_variable
less 16 20 1783 1787 O
than 21 25 1788 1792 O
or 26 28 1793 1795 O
equal 29 34 1796 1801 O
to 35 37 1802 1804 O
( 38 39 1805 1806 O
< 39 40 1806 1807 O
=) 40 42 1807 1809 O
1.5 43 46 1810 1813 B-upper_bound
times 47 52 1814 1819 I-upper_bound
the 53 56 1820 1823 I-upper_bound
upper 57 62 1824 1829 I-upper_bound
limit 63 68 1830 1835 I-upper_bound
of 69 71 1836 1838 I-upper_bound
normal 72 78 1839 1845 I-upper_bound
( 79 80 1846 1847 I-upper_bound
ULN 80 83 1847 1850 I-upper_bound
) 83 84 1850 1851 I-upper_bound
of 85 87 1852 1854 O
each 88 92 1855 1859 O
institution 93 104 1860 1871 O

who 0 3 1872 1875 O
are 4 7 1876 1879 O
currently 8 17 1880 1889 O
receiving 18 27 1890 1899 O
steroids 28 36 1900 1908 B-treatment
at 37 39 1909 1911 O
a 40 41 1912 1913 O
dose 42 46 1914 1918 O
of 47 49 1919 1921 O
< 50 51 1922 1923 O
= 51 52 1923 1924 O
10 52 54 1924 1926 B-upper_bound
mg 55 57 1927 1929 I-upper_bound
/ 57 58 1929 1930 I-upper_bound
day 58 61 1930 1933 I-upper_bound
do 62 64 1934 1936 O
not 65 68 1937 1940 O
need 69 73 1941 1945 O
to 74 76 1946 1948 O
discontinue 77 88 1949 1960 O
steroids 89 97 1961 1969 O
prior 98 103 1970 1975 O
to 104 106 1976 1978 O
enrollment 107 117 1979 1989 O

who 0 3 1990 1993 O
developed 4 13 1994 2003 O
autoimmune 14 24 2004 2014 B-chronic_disease
disorders 25 34 2015 2024 I-chronic_disease
of 35 37 2025 2027 O
Grade 38 43 2028 2033 O
< 44 45 2034 2035 O
=3 45 47 2035 2037 O
may 48 51 2038 2041 O
enroll 52 58 2042 2048 O
if 59 61 2049 2051 O
the 62 65 2052 2055 O
disorder 66 74 2056 2064 O
has 75 78 2065 2068 O
resolved 79 87 2069 2077 O
to 88 90 2078 2080 O
Grade 91 96 2081 2086 O
< 97 98 2087 2088 O
= 98 99 2088 2089 O
1 99 100 2089 2090 B-upper_bound
and 101 104 2091 2094 O
the 105 108 2095 2098 O
participant 109 120 2099 2110 O
has 121 124 2111 2114 O
been 125 129 2115 2119 O
off 130 133 2120 2123 O
systemic 134 142 2124 2132 B-treatment
steroids 143 151 2133 2141 I-treatment
at 152 154 2142 2144 O
doses 155 160 2145 2150 O
greater 161 168 2151 2158 O
than 169 173 2159 2163 O
( 174 175 2164 2165 O
> 175 176 2165 2166 O
) 176 177 2166 2167 O
10 178 180 2168 2170 B-lower_bound
milligrams 181 191 2171 2181 I-lower_bound
per 192 195 2182 2185 I-lower_bound
day 196 199 2186 2189 I-lower_bound
( 200 201 2190 2191 I-lower_bound
mg 201 203 2191 2193 I-lower_bound
/ 203 204 2193 2194 I-lower_bound
day 204 207 2194 2197 I-lower_bound
) 207 208 2197 2198 I-lower_bound
for 209 212 2199 2202 O
at 213 215 2203 2205 O
least 216 221 2206 2211 O
2 222 223 2212 2213 B-lower_bound
weeks 224 229 2214 2219 I-lower_bound

who 0 3 2220 2223 O
have 4 8 2224 2228 O
a 9 10 2229 2230 O
history 11 18 2231 2238 O
of 19 21 2239 2241 O
adrenal 22 29 2242 2249 B-chronic_disease
insufficiency 30 43 2250 2263 I-chronic_disease

who 0 3 2264 2267 O
have 4 8 2268 2272 O
had 9 12 2273 2276 O
SD 13 15 2277 2279 O
must 16 20 2280 2284 O
have 21 25 2285 2289 O
been 26 30 2290 2294 O
on 31 33 2295 2297 O
pembrolizumab 34 47 2298 2311 B-treatment
for 48 51 2312 2315 O
at 52 54 2316 2318 O
least 55 60 2319 2324 O
12 61 63 2325 2327 B-lower_bound
weeks 64 69 2328 2333 I-lower_bound

who 0 3 2334 2337 O
have 4 8 2338 2342 O
previously 9 19 2343 2353 O
received 20 28 2354 2362 O
any 29 32 2363 2366 O
anti 33 37 2367 2371 B-treatment
- 37 38 2371 2372 I-treatment
PD-1 38 42 2372 2376 I-treatment
/ 42 43 2376 2377 I-treatment
PD 43 45 2377 2379 I-treatment
- 45 46 2379 2380 I-treatment
L1 46 48 2380 2382 I-treatment
therapy 49 56 2383 2390 I-treatment
, 56 57 2390 2391 O
alone 58 63 2392 2397 O
or 64 66 2398 2400 O
in 67 69 2401 2403 O
combination 70 81 2404 2415 O

